Matches in Wikidata for { <http://www.wikidata.org/entity/Q61810043> ?p ?o ?g. }
- Q61810043 description "article publié dans la revue scientifique British Medical Journal" @default.
- Q61810043 description "artículu científicu" @default.
- Q61810043 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61810043 description "scientific article published in the British Medical Journal" @default.
- Q61810043 description "wetenschappelijk artikel" @default.
- Q61810043 description "наукова стаття, опублікована в січні 2019" @default.
- Q61810043 name "Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study" @default.
- Q61810043 name "Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study" @default.
- Q61810043 type Item @default.
- Q61810043 label "Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study" @default.
- Q61810043 label "Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study" @default.
- Q61810043 prefLabel "Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study" @default.
- Q61810043 prefLabel "Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study" @default.
- Q61810043 P1433 Q61810043-4C92E98B-9B4F-4A0A-9F5E-9EB2F182A843 @default.
- Q61810043 P1476 Q61810043-33713BF2-E4A8-4002-B963-AB4CB365FEC1 @default.
- Q61810043 P2093 Q61810043-1A3B7269-CCE0-4AAE-9B0A-1A0C04F0286A @default.
- Q61810043 P2093 Q61810043-509C79EE-B5CD-4445-9792-058857BEAE79 @default.
- Q61810043 P2093 Q61810043-5E9F0F29-EE94-48AB-BD09-A7032FC835F3 @default.
- Q61810043 P2093 Q61810043-681B5BC6-2EE6-4E53-94D3-8D582A5C5A95 @default.
- Q61810043 P2093 Q61810043-974909D6-0BF1-4B91-8F0C-B98FBF93E78B @default.
- Q61810043 P2093 Q61810043-C13380CC-3088-46FF-844E-66AB0E5C7F95 @default.
- Q61810043 P2860 Q61810043-03803CB9-086B-485D-9852-AA4D52972910 @default.
- Q61810043 P2860 Q61810043-04F1E750-FDA6-45D6-BAF8-C14C1532ECC9 @default.
- Q61810043 P2860 Q61810043-187A71E1-19D4-49B6-A875-C0E5231B0137 @default.
- Q61810043 P2860 Q61810043-1AF2C743-AAC2-43C1-BFCF-9767CA35F701 @default.
- Q61810043 P2860 Q61810043-1B9E36AF-AFED-48F9-BAC3-BC1F0EB12C78 @default.
- Q61810043 P2860 Q61810043-20EEA6ED-1F2E-4A17-8C3A-B0B8A8730B4A @default.
- Q61810043 P2860 Q61810043-28382CA0-3EED-4113-AAA0-CA65E0610D08 @default.
- Q61810043 P2860 Q61810043-2CD499EE-B9B3-4783-AC0A-ABB22B17CE75 @default.
- Q61810043 P2860 Q61810043-2F94D52B-3A2E-4AFA-8DE9-65AEBFBEF3D6 @default.
- Q61810043 P2860 Q61810043-3037CEFA-4E01-46D1-A3AA-5BC579A95315 @default.
- Q61810043 P2860 Q61810043-4BDE0CDA-10EB-44C4-861F-78C84B1C9D7D @default.
- Q61810043 P2860 Q61810043-4D37625F-53A6-4D28-8D7C-436757C0037E @default.
- Q61810043 P2860 Q61810043-5282720A-02F9-4683-A76A-CCF73E7DF763 @default.
- Q61810043 P2860 Q61810043-56690D26-15B5-42C6-88A3-F8994EAA0644 @default.
- Q61810043 P2860 Q61810043-5BB93FF1-EE50-4AC4-AEC8-87BA9DBAF529 @default.
- Q61810043 P2860 Q61810043-843B1D4E-31CF-4D1D-B2BF-773C13702713 @default.
- Q61810043 P2860 Q61810043-8C5F630E-2FAC-4D8D-9A9D-4C612E7F49A4 @default.
- Q61810043 P2860 Q61810043-A9837312-47ED-4DF4-8953-02328705E085 @default.
- Q61810043 P2860 Q61810043-A9EA74FA-9C8B-4591-8AE3-50F2FA13D546 @default.
- Q61810043 P2860 Q61810043-B96BF716-48E8-4D21-BEF1-751B63B46AF0 @default.
- Q61810043 P2860 Q61810043-C2DCAF53-871C-4CA7-8E51-7FDAA9797015 @default.
- Q61810043 P2860 Q61810043-C564D553-7FCE-40E1-8C2D-0C9ABAD131DE @default.
- Q61810043 P2860 Q61810043-C6289C65-52C9-48AF-9718-2EB8500371A4 @default.
- Q61810043 P2860 Q61810043-CDAF9050-A810-4CD3-95AD-0CDAE726F9E6 @default.
- Q61810043 P2860 Q61810043-DF7FF7FF-85DE-4484-B2B6-11D0C09460BF @default.
- Q61810043 P2860 Q61810043-F77802A0-B30F-4688-8727-62EF38A31D00 @default.
- Q61810043 P304 Q61810043-D49D6771-3C88-47F2-A009-4874137D8EE1 @default.
- Q61810043 P31 Q61810043-A718B30F-C38C-464E-A707-2C890E517186 @default.
- Q61810043 P356 Q61810043-2BC099B5-2075-4E5B-A63D-8E3D10BDBDC0 @default.
- Q61810043 P407 Q61810043-BC27D73B-E755-45C8-A801-A899342CB62E @default.
- Q61810043 P478 Q61810043-0C2651E6-E3D5-42AD-BF1E-A91D5762B237 @default.
- Q61810043 P50 Q61810043-10545F44-9677-4D4A-ABE2-3B7CD28F6307 @default.
- Q61810043 P50 Q61810043-30A6EBAA-DEE2-4BA8-B6F6-E1E5B79120BE @default.
- Q61810043 P50 Q61810043-3ECF5CFD-F806-40C0-BCB1-24D11690BA53 @default.
- Q61810043 P50 Q61810043-47E0BF4E-3C30-4D3C-AF5D-02D898784B53 @default.
- Q61810043 P50 Q61810043-4F0C6455-2797-416F-B69D-49063A05B5DB @default.
- Q61810043 P50 Q61810043-6BBBCB2C-C44F-4054-8ABF-A208269BA5EB @default.
- Q61810043 P50 Q61810043-7AB07F96-4512-4BA3-AE78-5880C1ED1380 @default.
- Q61810043 P50 Q61810043-B644C1BE-0D40-4410-8783-4A426D48E8AF @default.
- Q61810043 P50 Q61810043-BDA7734C-B5B4-410D-AABF-F66C78D6651A @default.
- Q61810043 P50 Q61810043-DE663400-6E44-414D-AC16-DE222D58CADB @default.
- Q61810043 P577 Q61810043-3CA04E07-C610-4D07-BF15-E010FF9A54B8 @default.
- Q61810043 P698 Q61810043-0BB181B3-9BA6-41C6-8B5C-742BC659E3DD @default.
- Q61810043 P921 Q61810043-00668CD2-694E-4727-AA83-6DEF84B9050D @default.
- Q61810043 P921 Q61810043-591BB21B-DC4B-48D2-827F-9B29467ABBED @default.
- Q61810043 P921 Q61810043-5F925436-2220-4321-9A7B-B8040A6F97FB @default.
- Q61810043 P932 Q61810043-4C0B1C32-FBFC-4231-8A73-5A903CA38BFF @default.
- Q61810043 P356 BMJ.L67 @default.
- Q61810043 P698 30679233 @default.
- Q61810043 P1433 Q546003 @default.
- Q61810043 P1476 "Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study" @default.
- Q61810043 P2093 "Arnaud Constantin" @default.
- Q61810043 P2093 "Gabriel Baron" @default.
- Q61810043 P2093 "Jacques Morel" @default.
- Q61810043 P2093 "Philippe Ravaud" @default.
- Q61810043 P2093 "Rene-Marc Flipo" @default.
- Q61810043 P2093 "Thomas Bardin" @default.
- Q61810043 P2860 Q29619287 @default.
- Q61810043 P2860 Q33767771 @default.
- Q61810043 P2860 Q34276905 @default.
- Q61810043 P2860 Q34795777 @default.
- Q61810043 P2860 Q35963563 @default.
- Q61810043 P2860 Q36225803 @default.
- Q61810043 P2860 Q37465523 @default.
- Q61810043 P2860 Q37466558 @default.
- Q61810043 P2860 Q37707612 @default.
- Q61810043 P2860 Q37811639 @default.
- Q61810043 P2860 Q37980421 @default.
- Q61810043 P2860 Q39885959 @default.
- Q61810043 P2860 Q40055726 @default.
- Q61810043 P2860 Q40597607 @default.
- Q61810043 P2860 Q42245812 @default.
- Q61810043 P2860 Q43205844 @default.
- Q61810043 P2860 Q44165611 @default.
- Q61810043 P2860 Q44726792 @default.
- Q61810043 P2860 Q44774931 @default.
- Q61810043 P2860 Q44951448 @default.
- Q61810043 P2860 Q45803075 @default.
- Q61810043 P2860 Q52840577 @default.